File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/all.16270
- Scopus: eid_2-s2.0-85200479165
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Impact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial
Title | Impact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial |
---|---|
Authors | |
Keywords | clinical trial drug allergy education multidisciplinary non-allergist |
Issue Date | 1-Jan-2024 |
Publisher | Wiley |
Citation | Allergy, 2024 How to Cite? |
Abstract | Background: The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non-specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence-based interventions to better equip non-specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non-specialists. Methods: A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course—Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self-reported practices were assessed with standardized questionnaires (scored from 0 to 100, with “satisfactory” defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts. Results: Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self-reported practice (36.9 ± 24.3) were unsatisfactory among non-specialists, with significantly lower scores from nurses than physicians in both domains (knowledge: 49.0 ± 17.4 vs. 74.0 ± 12.7; practice: 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self-reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively. Conclusions: ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non-specialists. Further longitudinal studies are required to evaluate long-term impact. |
Persistent Identifier | http://hdl.handle.net/10722/346282 |
ISSN | 2023 Impact Factor: 12.6 2023 SCImago Journal Rankings: 3.073 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lucas, Michaela | - |
dc.contributor.author | Mak, Hugo W.F. | - |
dc.contributor.author | Lee, Jasmine T.Y. | - |
dc.contributor.author | Kulkarni, Rishabh | - |
dc.contributor.author | Chan, Sophia S.C. | - |
dc.contributor.author | Li, Philip H. | - |
dc.date.accessioned | 2024-09-13T00:30:11Z | - |
dc.date.available | 2024-09-13T00:30:11Z | - |
dc.date.issued | 2024-01-01 | - |
dc.identifier.citation | Allergy, 2024 | - |
dc.identifier.issn | 0105-4538 | - |
dc.identifier.uri | http://hdl.handle.net/10722/346282 | - |
dc.description.abstract | Background: The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non-specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence-based interventions to better equip non-specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non-specialists. Methods: A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course—Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self-reported practices were assessed with standardized questionnaires (scored from 0 to 100, with “satisfactory” defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts. Results: Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self-reported practice (36.9 ± 24.3) were unsatisfactory among non-specialists, with significantly lower scores from nurses than physicians in both domains (knowledge: 49.0 ± 17.4 vs. 74.0 ± 12.7; practice: 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self-reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively. Conclusions: ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non-specialists. Further longitudinal studies are required to evaluate long-term impact. | - |
dc.language | eng | - |
dc.publisher | Wiley | - |
dc.relation.ispartof | Allergy | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | clinical trial | - |
dc.subject | drug allergy | - |
dc.subject | education | - |
dc.subject | multidisciplinary | - |
dc.subject | non-allergist | - |
dc.title | Impact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/all.16270 | - |
dc.identifier.scopus | eid_2-s2.0-85200479165 | - |
dc.identifier.eissn | 1398-9995 | - |
dc.identifier.issnl | 0105-4538 | - |